Palliative care planning for people with liver cirrhosis
Tests advance care planning with a contact nurse in people with liver cirrhosis.
Key facts
- Who runs it
- Esbjerg Hospital - University Hospital of Southern Denmark
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Palliative Care for Patients With Liver Cirrhosis
- Status
- Enrolling by invitation
- People taking part
- 200 people, planned
- Started
- 1 Aug 2023
- Expected to end
- 1 Aug 2028
- Type of study
- Observational, 2 groups
- Treatments tested
- Advance Care Planning and the consequent actions
- Record updated
- 5 March 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with liver cirrhosis who need palliative support. Palliative support means care to ease symptoms and plan future care.
- Age
- 18 years and older
- Sex
- All sexes can join
- Disease stage
- Liver cirrhosis of any cause, as the main long-term illness. At least 2 items checked on the Supportive and Palliative Care Indicators Tool (SPICT™).
- Earlier treatment
- People already in contact with specialized palliative care teams or a hospice cannot join.
Main reasons for not taking part
- Unable to give informed consent
- Younger than 18 years
- Ongoing contact with specialized palliative care teams or hospice
- Another chronic life-threatening illness is more likely to cause death within 1-2 years
- The patient and relatives have not said they want palliative support
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Liver cirrhosis of any etiology (diagnosed clinically, by imaging or histological features) as predominant chronic illness
- 2 or more items checked on the Supportive and Palliative Care Indicators Tool (SPICT™, appendix)
- Expressed desire for palliative support from the patient and relatives
- Ability to give informed consent
Who cannot take part
- Other chronic life-threatening illness than liver cirrhosis is more likely to become the cause of death within 1-2 years
- Age < 18 years
- Inability to give informed consent
- Ongoing contact with specialized palliative care teams or hospice
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Background: Patients with liver cirrhosis rarely receive palliative care although the Danish Health Authorities and WHO recommend it. The lacking palliative intervention is probably owed to a physician culture focused on life-prolonging active treatment at any cost and unclarities, and misperceptions about palliative care, which is perceived by many as exclusively for cancer patients and something that marks the end of active treatment.
Read full original descriptionShow less
Study aim: Measure the effect of palliative care on the patient burden, caregiver burden, and the utilization of healthcare services.
Study design: Prospective multi-center intervention study with end of study at the patients' death. We will use a 3-faceted endpoint 1) Patient burden measured by change in Hospital Anxiety and Depression Scale, 2) caregiver burden by a change in Zarit Caregiver Burden Questionnaire, and 1) health care system burden as the difference in number, length, and indication for hospital admissions and need for outpatient services.
Patients: We will prospectively include 200 patients with liver cirrhosis (approx. 50 from each of 4-5 sites: Esbjerg, Herlev, Hvidovre, Århus) who have 2 or more items checked on the Supportive and Palliative Care Indicators Tool. Control groups will be identified from two non-participating hospitals and matched regarding age, gender, number of comorbidities, and alcohol and caregiver status.
Methods: The intervention will be advanced care planning with conversations and actions built around a standardized symptom identification tool (EORTC QLQ-C15-PAL). Advance care planning is the collaborative process between patients and health care professionals of planning future health care. The assignment of a contact nurse to each participant is a key part of the intervention.
Results: We will measure patient and caregiver burden at inclusion, after 4-6 weeks, 4-6 months, and every 6 months until the patient dies. All use of health care services will be registered. The use of health care services during the terminal 2 years will be compared that of control patients.
The 2 groups in the trial
- Palliative Care arm
Intervention by Advance care planning (ACP) conversation:The goal is the identification, assessment, and treatment of physical, psychosocial, or spiritual symptoms and problems. Advance care actions:These are the actions taken to fulfill the advance care plan and can include, but are not limited to:treatments: pharmacological, psychosocial (priest, psychologist, etc.) referrals: rehabilitation, specialized palliative care team, hospice, etc. communication initiatives with relatives, primary care, public authorities
Treatment: Advance Care Planning and the consequent actions
- Non-participating arm
Will continue standard of care
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Palliative Care for Patients With Liver Cirrhosis - a Multicentre Intervention Study
- Plain-language title
- Palliative care planning for people with liver cirrhosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- LiverCare - a palliative care intervention for patients with liver cirrhosis: study protocol for a multi-center, pragmatic, non-randomised clinical trial.BMC palliative care, 2026
- The LiverCare intervention: implementing structured palliative care in hepatology - a multicenter mixed-methods feasibility study in patients with cirrhosis.BMC palliative care, 2026
- Record updated
- 5 March 2025